New database aims to reduce bone cancer surgery risks
NCT ID NCT07669103
First seen Jun 25, 2026 · Last updated Jun 30, 2026 · Updated 3 times
Summary
This study will collect information from 400 people having surgery for bone cancer. The goal is to track complications like infections or blood clots and understand how to improve care. By analyzing this data, researchers hope to find ways to make surgery safer and recovery faster.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better predict and prevent complications after bone cancer surgery, leading to safer procedures.
- What could go wrong
- This is an observational study, not a treatment trial. It only collects data and won't directly improve outcomes for participants. Results may take years to influence practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 400 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
Jul 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
patients undergoing elective bone cancer resection surgery
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Clinical diagnosis of bone cancer 2. Scheduled to undergo elective bone cancer resection surgery Exclusion Criteria: 1. Unable to comply with follow-up 2. declined participation in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bone cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
The Second Affiliated Hospital of Zhejiang University anesthesiology department
Hangzhou, Zhejiang, 310000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive injection target bone tumors? a Dose-Finding trial aims to find out
- Hip bone reconstruction after cancer: a 30-Year review
- New hope for rare bone cancer: targeted drugs enter early trial
- New knee prosthesis helps bone cancer patients walk again
- New drug shows promise for stubborn cancers
- Sound waves vs. bone pain: can ultrasound replace radiation?